Compile Data Set for Download or QSAR
Report error Found 25 Enz. Inhib. hit(s) with all data for entry = 100
TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173886(US9688645, 1-1)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173906(US9688645, 3-1)
Affinity DataIC50: 7.70nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173904(US9688645, 2-1)
Affinity DataIC50: 8.80nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173918(US9688645, 5-2)
Affinity DataIC50: 9nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173923(US9688645, 6-3)
Affinity DataIC50: 12nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173908(US9688645, 4-1)
Affinity DataIC50: 17nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173903(US9688645, 1-9)
Affinity DataIC50: 19nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173922(US9688645, 6-2)
Affinity DataIC50: 21nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173926(US9688645, 7-1)
Affinity DataIC50: 22nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173929(US9688645, 8-1)
Affinity DataIC50: 23nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173902(US9688645, 1-8)
Affinity DataIC50: 29nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173920(US9688645, 5-3)
Affinity DataIC50: 32nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173930(US9688645, 8-2)
Affinity DataIC50: 33nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173928(US9688645, 7-4)
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173900(US9688645, 1-7)
Affinity DataIC50: 49nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173921(US9688645, 6-1)
Affinity DataIC50: 52nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173932(US9688645, 6-6)
Affinity DataIC50: 53nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173924(US9688645, 6-4)
Affinity DataIC50: 55nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173931(US9688645, 8-3)
Affinity DataIC50: 59nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173897(US9688645, 1-4)
Affinity DataIC50: 71nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173898(US9688645, 1-5)
Affinity DataIC50: 105nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173894(US9688645, 1-3)
Affinity DataIC50: 269nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173911(US9688645, 5-1)
Affinity DataIC50: 649nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173899(US9688645, 1-6)
Affinity DataIC50: 811nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent

TargetCarboxypeptidase B2(Human)
Sanofi

US Patent
LigandPNGBDBM173893(US9688645, 1-2)
Affinity DataIC50: 9.04E+3nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2018
Entry Details
Go to US Patent